Regencell Bioscience Holdings Ltd
Stock Chart, Company Information, and Scan Results
$5.54(as of Aug 25, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regencell Bioscience Holdings Ltd Company Information, Fundamentals, and Technical Indicators
Stock Price$5.54
Ticker SymbolRGC
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees10
CountyUSA
Market Cap$2,620.8M
EBIDTA-7.1M
P/E Ratio0.00
Forward P/E Ratio0.00
Earnings per Share-0.01
Profit Margin0.00%
RSI38.04
Shares Outstanding494.5M
ATR0.63
52-Week High69.00
Volume149,955
52-Week Low4.51
Book Value0.0M
P/B Ratio0.00
Upper Keltner6.98
P/S Ratio0.00
Lower Keltner4.16
Next Earnings Date10/28/2026
Cash Surplus0.0M
Next Ex-Dividend DateUnknown
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Holdings Ltd In Our Stock Scanner
As of Aug 24, 2026
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.